TY  - JOUR
AU  - Zhao, Yujia
AU  - Lai, Yunjia
AU  - Konijnenberg, Hilde
AU  - Huerta, José María
AU  - Vinagre-Aragon, Ana
AU  - Sabin, Jara Anna
AU  - Hansen, Johnni
AU  - Petrova, Dafina
AU  - Sacerdote, Carlotta
AU  - Zamora-Ros, Raul
AU  - Pala, Valeria
AU  - Heath, Alicia K
AU  - Panico, Salvatore
AU  - Guevara, Marcela
AU  - Masala, Giovanna
AU  - Lill, Christina M
AU  - Miller, Gary W
AU  - Peters, Susan
AU  - Vermeulen, Roel
TI  - Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort.
JO  - Neurology
VL  - 102
IS  - 8
SN  - 0028-3878
CY  - [Erscheinungsort nicht ermittelbar]
PB  - Ovid
M1  - DKFZ-2024-00601
SP  - e209201
PY  - 2024
AB  - Inverse associations between caffeine intake and Parkinson disease (PD) have been frequently implicated in human studies. However, no studies have quantified biomarkers of caffeine intake years before PD onset and investigated whether and which caffeine metabolites are related to PD.Associations between self-reported total coffee consumption and future PD risk were examined in the EPIC4PD study, a prospective population-based cohort including 6 European countries. Cases with PD were identified through medical records and reviewed by expert neurologists. Hazard ratios (HRs) and 95
KW  - Humans
KW  - Caffeine: metabolism
KW  - Coffee
KW  - Parkinson Disease: diagnosis
KW  - Parkinson Disease: epidemiology
KW  - Parkinson Disease: etiology
KW  - Case-Control Studies
KW  - Prospective Studies
KW  - Risk Factors
KW  - Caffeine (NLM Chemicals)
KW  - Coffee (NLM Chemicals)
LB  - PUB:(DE-HGF)16
C6  - pmid:38513162
DO  - DOI:10.1212/WNL.0000000000209201
UR  - https://inrepo02.dkfz.de/record/289134
ER  -